Related Experiment Video
Updated: Aug 9, 2026

Culture of myeloid dendritic cells from bone marrow precursors
Published on: July 26, 2008
Disparate functions of immature and mature human myeloid dendritic cells: implications for dendritic cell-based
Katharina Tschoep1, Thomas C Manning, Helena Harlin
1Department of Pathology, Section of Hematology/Oncology, University of Chicago, Illinois, USA. tgajewsk@medicine.bsd.uchicago.edu
Insights
Immature and mature dendritic cells (DC) have distinct roles in antitumor vaccines. Immature DCs excel at cytokine production, while mature DCs are better at T cell priming, suggesting specialized functions for optimal immunotherapy.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- Dendritic cells (DCs) are crucial for initiating immune responses and are investigated for cancer vaccines.
- The optimal differentiation state of DCs for antitumor vaccines remains unclear.
- Key DC functions for immunization include co-stimulatory molecule expression, cytokine production, and chemokine receptor-mediated migration.
Purpose of the Study:
- To compare the functional properties of immature and mature human monocyte-derived dendritic cells (moDCs) relevant to their potential as antitumor vaccines.
- To investigate whether critical functions for T cell priming are co-expressed in a single DC subset.
Main Methods:
- Purification of human monocyte-derived immature and mature DCs from healthy donors and cancer patients.
- Assessment of CD80/86 expression, cytokine production after CD40 ligation, and migration to CCL19/CCL21 (chemokine receptor 7 ligands).
- Evaluation of the impact of maturation conditions and lipopolysaccharide stimulation on DC function and Toll-like receptor expression.
Main Results:
- Mature DCs exhibited high expression of CD80/86 and robust migration to CCL19/CCL21.
- Immature DCs demonstrated superior cytokine production following CD40 engagement compared to mature DCs.
- Loss of cytokine secretion capacity was observed during DC maturation and with lipopolysaccharide stimulation, correlating with reduced Toll-like receptor expression.
Conclusions:
- Immature and mature DCs do not co-express all functions critical for optimal T cell priming.
- Immature and mature DCs likely possess distinct CD40-mediated signaling pathways, influencing their immunogenic potential.
- These findings suggest that distinct DC subsets may be required for different stages of an effective antitumor immune response.
Abstract:
Although antigen-loaded dendritic cells (DC) are being investigated as antitumor vaccines, which DC differentiation state is most effective is not clear. Three DC functions that may be critical for immunization potential are expression of CD80/86, cytokine production following CD40 engagement, and migration to chemokine receptor 7-binding chemokines. We therefore examined highly purified human monocyte-derived immature and mature DC for these properties from normal donors and cancer patients. Although high expression of CD80/86 and migration to 6Ckine + macrophage-inflammatory protein-3beta were properties of mature DC, cytokine production following CD40 ligation was superior by immature DC. Loss of cytokine secretion occurred with multiple maturation conditions, was not apparently reversible, and was also seen with lipopolysaccharide stimulation in correlation with down-regulated Toll-like receptor expression. Our results suggest that the functions thought to contribute to optimal T cell priming are not coexpressed by the same DC population and that immature and mature DC likely possess distinct CD40-mediated signaling events.
Related Concept Videos
Cell-mediated Immune Responses
Vaccinations
Cells of the Adaptive Immune Response
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Vaccines

